HOME >> BIOLOGY >> NEWS
Report calls for improved monoclonal antibodies against solid tumors

A new report by leading experts in monoclonal antibody research for oncology offers a conceptual framework for future research in the design of antibody therapies against solid tumors. Writing in the January 15, 2007 issue of CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer Society, the researchers note that 85 percent of cancers involve solid tumors, but only 25 percent of approved antibody therapies are directed at solid tumor targets. The researchers suggest manipulation of the physical properties of a monoclonal antibody as a potentially effective way to improve antibody treatments for solid tumors.

Monoclonal antibodies ability to target a single specific protein on cancer cells, has led to their being called a magic bullet that targets only cancer cells while minimizing collateral damage to healthy tissue. That damage causes the toxicity associated with chemotherapy and radiation therapy. In the nearly 20 years since scientists were able to create monoclonal antibodies that could be safely used in humans, eight monoclonal antibodies have been approved for use in clinical treatments to trigger immune responses to cancer cells, modulate cancer cell growth, and deliver drugs to cancer cells. Of these, only three are used on solid tumors. However, solid tumors account for 85 percent of all cancers.

According to review lead author Robert A. Beckman, M.D. of the Department of Clinical Hematology and Oncology at Centocor Research & Development, Inc. in Malvern, PA and his co-authors, Louis M. Weiner, M.D. of Fox Chase Cancer Center in Philadelphia and Hugh M. Davis, Ph.D. of the Department of Clinical Pharmacology and Experimental Medicine at Centocor, a major difficulty in developing monoclonal antibody treatments for solid tumors has been their ability to penetrate the tumor. To be effective, the treatment must gain acce
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
11-Dec-2006


Page: 1 2

Related biology news :

1. Report recommends off-site disposal of secondary waste
2. SNM initiatives supported by inclusions in NAS Report on competitiveness of US chemistry research
3. AAAS/EurekAlert! refocus on China with 2007 Fellowships for Science Reporters in Developing Regions
4. Report outlines funding to conserve half of Massachusettss land
5. Report challenges common ecological hypothesis about species abundance
6. Report highlights change in Canadas forests
7. Report: Canadas Yellowstone too small for wildlife
8. Report warns about carbon dioxide threats to marine life
9. Report focuses on the role good microbes play in future medicine
10. Herringtons annual 2006 State of the Shore Report, May 22
11. Report finds cruise industry is protecting the precious places it visits

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... Join Jonathan Riek, PhD, VP, ... on Tuesday, September 10, 2019 at 1pm EDT to learn about two common imaging ... , NAFLD is the most common diffuse liver disease, with a worldwide prevalence ...
(Date:8/9/2019)... ... ... With a demand in healthcare to lower unneeded emergency room visits and provide ... in the coming years, according to a new report on the industry by market ... is a detailed look at the current state of these healthcare outlets, including the ...
(Date:8/6/2019)... , ... August 06, 2019 , ... ... and environmental concerns. One plant-based food in particular quickly entered the limelight – ... product developers use a thermogelling and emulsifying ingredient such as methyl cellulose. This ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... 06, 2019 , ... The San Diego Biotechnology Network (SDBN) ... SDBN BUZZ podcast focused on connecting the region’s biotech community and discussing topics ... the region and attract external employers, investors, scientists, and others who wish to ...
(Date:8/6/2019)... ... August 05, 2019 , ... Advanced Clinical, ... as a distinguished leader by PharmaVOICE magazine, earning him a prestigious spot on ... magazine’s July/August special issue. , As the executive vice president of business development ...
(Date:8/4/2019)... , ... August 02, 2019 , ... Cirtec Medical Corporation, ... devices, today announced that it has begun construction on a 30,000 sq. ft. ... miles from San Jose. , The facility, which is expected to be fully ...
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , an exclusive ... announces its Boston BD conference to be held on September 10, ... Boston , the event provides an opportunity for attendees to leverage insight from ...
Breaking Biology Technology:
Cached News: